Navigation Links
Arisaph Pharmaceuticals Reports Positive Results From Two Safety Clinical Trials For Its Niacin Analog (ARI-3037MO)
Date:11/7/2012

BOSTON, Nov. 7, 2012 /PRNewswire/ --

  • ARI-3037MO was well tolerated in single and repeat ascending dose trials in healthy volunteers
  • ARI-3037MO did not provoke flushing or any other treatment-related adverse effects in 58 healthy male and female volunteers
  • ARI-3037MO was well absorbed orally and plasma levels demonstrated good dose proportionality
  • ARI-3037MO showed encouraging lipid changes in both clinical trials in healthy subjects
  • Arisaph Pharmaceuticals, Inc. announced today during an oral presentation at the American Heart Association (AHA) meeting in Los Angeles, CA that its niacin analog, ARI-3037MO, was extremely well tolerated in a single-ascending dose (SAD) and a multiple-ascending dose (MAD) trial in healthy male and female volunteers.  The results showed that ARI-3037MO did not provoke flushing or any other adverse skin changes, nor did it cause increases in liver enzymes or blood glucose at doses up to 6 grams per day. In both clinical trials, ARI-3037MO also demonstrated encouraging lipid effects. Based on these promising results, ARI-3037MO potentially represents a transformational, new niacin-like option for treatment of patients with dyslipidemia, especially in the setting of metabolic syndrome, a disorder that afflicts as many as 70 million Americans1

    (Logo: http://photos.prnewswire.com/prnh/20110321/NE69091LOGO )

    "The absence of flushing and other niacin induced adverse events highlights a differentiated safety profile for our novel niacin analog," said Christopher P. Kiritsy, Co-Founder, President and Chief Executive Officer of Arisaph Pharmaceuticals. "Moreover, the evidence of lipid changes in such short duration trials in healthy volunteers shows that our preclinical efficacy data are translating and breeds optimism for the development of our best-in-class niacin analog."In two placebo co
    '/>"/>

    SOURCE Arisaph Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. Oramed Pharmaceuticals to Present at the 12th Annual Diabetes Technology Society Meeting in Bethesda, MD, Nov 8-10, 2012
    2. Optimer Pharmaceuticals to Present at November 2012 Investor Conferences
    3. Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results
    4. Isis Pharmaceuticals To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
    5. Vanda Pharmaceuticals Reports Third Quarter 2012 Results
    6. Radiopharmaceuticals and Contrast Media: Frost & Sullivan Predicts Market Growth in Europe
    7. Keryx Biopharmaceuticals, Inc. To Host Conference Call on Third Quarter 2012 Financial Results
    8. Enanta Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
    9. Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2012 Financial Results
    10. AcelRx Pharmaceuticals Reports Third Quarter 2012 Financial Results
    11. Thom Rowland Joins Arbor Pharmaceuticals as Vice President of Commercial Operations
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/23/2014)... Sept. 23, 2014   MedNet Solutions , a global ... is pleased to announce that it will once again be ... (SCDM) Annual Conference, to be held this year from September ... , Nevada. MedNet team members, in conjunction with representatives from many ... will also be in attendance, will be providing demonstrations of ...
    (Date:9/23/2014)... ORLANDO, Fla. and DUBLIN ... Inc. (OTC-BB: TNIB) ("we" or the "Company"), a ... innovative therapies for autoimmune diseases in emerging nations, ... has approved our common stock for DTC,s Deposit ... Fast Automated Securities Transfer Service ("FAST") transfer agent ...
    (Date:9/23/2014)... Sept. 23, 2014  Hill-Rom (NYSE: HRC ... Health ( Renton, WA ), the nation,s ... the companies, existing relationship as Hill-Rom now becomes Providence ... capital bed frame and surface products. ... in the U.S.  It operates 34 hospitals, 475 physician ...
    Breaking Medicine Technology:MedNet Solutions - Proud To Sponsor The SCDM 2014 Annual Conference 2TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 2TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 3TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 4Hill-Rom Announces Seven-Year, Sole-Source Contract with Providence Health 2
    ... SILVER SPRING, Md., May 2, 2011 The U.S. ... used with diet and exercise, to improve blood glucose ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) People with Type ... insulin, a hormone that regulates the amount of glucose ...
    ... and SEATTLE, May 2, 2011 CMC Biologics, ... in Copenhagen, Denmark and Seattle, Washington USA, announced ... serve at its Chief Executive Officer. CMC Biologics, ... delivering  world class, fully integrated, biopharmaceutical process development ...
    Cached Medicine Technology:FDA Approves New Treatment for Type 2 Diabetes 2CMC Biologics Announces Appointment of New CEO 2
    (Date:9/23/2014)... 23, 2014 Dr. Connie Casad has announced ... to new office space at 12200 Park Central Drive, Suite ... office will be Park Cities Aesthetics, Optimal Health and Wellness, ... announcing her move, Dr. Casad said, “The patients’ comfort and ... select, we want them to always feel like their needs ...
    (Date:9/23/2014)... (HealthDay News) -- A test used to diagnose lung cancer ... lung infections are more common, a new analysis says. ... the use of what,s known as functional imaging. For lung ... used, according to the study authors. Cancerous tumors generally ... of the lungs that don,t have cancer, according to background ...
    (Date:9/23/2014)... Avid collector Andrew Hawley, from Vintage Rock Posters, announces ... concert posters. The Doors were a smash hit after the ... Seattle Eagles Auditorium concert was held on July 23. ... Auditorium in November the same year. The artist that created ... three colors. The poster is a split fountain silkscreen printed ...
    (Date:9/23/2014)... September 23, 2014 What: Rutgers ... Upper West Side that embodies the inclusion and ... Christians, Scripture and the Ecological Crisis, a public ... Rhodes Professor Emerita of Old Testament at Louisville ... ancient wisdom that lends insight into current ecological ...
    (Date:9/23/2014)... CORVALLIS, Ore. A recent Oregon survey about an ... into the daily routine of elementary school students found ... students and teachers, and offered clear advantages for overly ... was developed and produced by the Healthy Youth Program ... and is available nationally. , Brain Breaks leads children ...
    Breaking Medicine News(10 mins):Health News:Dr. Connie Casad Moving to New Office Location 2Health News:Lung Infections May Hamper Ability to Detect Lung Cancer 2Health News:Inhabiting Eden: Christians, Scripture, and the Ecological Crisis – Public Lecture to Discuss Faith-Based Environmentalism 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 3
    ... is sheer torture for your aching back too. If ... bring relief. ,Inserting fine needles into the ... pain and even moderately severe depression. ,"Acupuncture ... such as migraines and arthrosis, but also stress and ...
    ... Minister Pranab Mukherjee who is undergoing treatment for head injuries ... discharged// on tomorrow. The minister met with a road accident ... to the doctors attending him. ,A team of ... found him "active and cheerful". ,"He is ...
    ... thought that hypoglycemic coma causes brain damage. On the contrary ... the coma//, as discovered by researchers from San Francisco VA ... ,The study results may have implications on the treatment of ... it can be applied to humans. ,Insulin is ...
    ... plus progestin shows a 24 percent reduction in risk for ... than 10 years after menopause. ,The analysis, ... in the Kronos Early Estrogen Prevention Study (KEEPS), also showed ... 50 to 59 using hormone therapy. ,However, the ...
    ... be frowned upon. ,Dancing at all-night raves combined ... fluids// can produce enormous harm. Ecstasy interferes with the ... in deaths due to kidney or cardiovascular failure brought ... campaigners could warn. ,But a new study ...
    ... between secondhand smoke and an increased risk of Mycobacterium tuberculosis ... with TB, according to a study published in the April ... be a "cause of great concern considering the high prevalence ... Boon of KNCV Tuberculosis Foundation in the Netherlands said. ...
    Cached Medicine News:Health News:Acupuncture Points Way to Relief from Many Ailments 2Health News:Recovering Pranab Mukherjee Likely to Be Discharged Tomorrow 2Health News:Glucose Causes Death of Brain Cells in Rodents Following Hypoglycemic Coma 2Health News:Glucose Causes Death of Brain Cells in Rodents Following Hypoglycemic Coma 3Health News:Early Estrogen Therapy May Reduce Cardiovascular Risks 2Health News:Study Finds Link Between Secondhand Smoke and TB Infection in Children 2
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    Medicine Products: